Quigley Company Asbestos Trust Fund
The Quigley Company, Inc. Asbestos Personal Injury Trust was created in 2013 after confirmation of Quigley’s Chapter 11 reorganization plan. The trust processes qualifying asbestos personal-injury claims under its Trust Distribution Procedures. This page uses official trust documents, federal court records and SEC filings for trust facts, claim values, funding history and current payment percentages.
Quigley Asbestos Trust Facts
| Trust | Quigley Company, Inc. Asbestos Personal Injury Trust |
|---|---|
| Quigley bankruptcy filing | September 3, 2004 |
| Trust created | 2013 |
| Reorganization effective | November 4, 2013 |
| Claims filing began | August 11, 2014 |
| Initial Claims Filing Date | February 11, 2015 |
| Reported contribution at plan effectiveness | Approximately $1.08 billion in cash and non-cash items contributed to Reorganized Quigley and the Asbestos PI Trust, according to Pfizer’s SEC filing |
| Estimated asbestos claims at petition date | Approximately 212,000 pending or expected claims, according to the bankruptcy court’s description of Quigley’s estimate |
| Current Non-Releasing claimant payment percentage | 13.3%, effective October 30, 2025 |
| Current Releasing claimant payment percentage | 3.3%, effective October 30, 2025 |
| Mesothelioma scheduled value | $200,000 |
| Mesothelioma maximum Individual Review value | $450,000 |
Important: The approximately $1.08 billion figure is a historical contribution value reported when the reorganization became effective; it is not the trust’s current asset balance. The approximately 212,000 figure describes Quigley’s estimate of pending or expected asbestos claims at the petition date, not the number ultimately paid by the trust.
Quigley Bankruptcy and Trust History
Quigley filed its Chapter 11 petition on September 3, 2004. Federal court records describe Quigley as a former Pfizer subsidiary facing extensive asbestos personal-injury liabilities. Quigley had manufactured asbestos-containing products including Insulag and Panelag.
The bankruptcy process ultimately produced the Quigley Company, Inc. Asbestos Personal Injury Trust. The official trust website states that the trust was created in 2013 following confirmation of the Fifth Amended and Restated Plan of Reorganization and was established to process, liquidate and pay valid asbestos personal-injury claims under the Trust Distribution Procedures.
Trust Funding and Asbestos Claim History
Pfizer’s SEC-filed 2013 Form 10-Q states that when the amended Quigley reorganization plan became effective on November 4, 2013, Pfizer contributed additional cash and non-cash items—including insurance proceeds and the value of certain debt forgiveness—to Reorganized Quigley and the Asbestos PI Trust with a value of approximately $1.08 billion.
Earlier bankruptcy-court records described proposed trust funding of approximately $645 million during an earlier version of the reorganization process. Because the plan changed before final effectiveness, this page uses the later SEC-reported approximately $1.08 billion contribution figure for the effective reorganization rather than presenting the earlier proposal as final funding.
The bankruptcy court also reported that Quigley estimated approximately 212,000 asbestos personal-injury claims were pending or would be asserted as of the petition date. That historical estimate should not be confused with claims received or paid by the trust after it began operating.
Disease Scheduled and Maximum Values
The current conformed Quigley Trust Distribution Procedures list disease levels, scheduled values and Individual Review maximum values. Scheduled and maximum values are claim-valuation figures, not guaranteed payments.
| Disease | Scheduled Value | Average Value | Maximum Value |
|---|---|---|---|
| Mesothelioma — Level VII | $200,000 | $225,000 | $450,000 |
| Lung Cancer 1 — Level VI | $35,000 | $45,000 | $90,000 |
| Lung Cancer 2 — Level V | Individual Review | $15,000 | $30,000 |
| Other Cancer — Level IV | $15,000 | $16,500 | $30,000 |
| Severe Asbestosis — Level III | $35,000 | $40,000 | $90,000 |
| Asbestosis/Pleural Disease — Level II | $5,000 | $5,000 | $5,000 |
| Asbestosis/Pleural Disease — Level I | $2,000 | Not separately listed as an Individual Review average | Scheduled-value limitation applies |
Current Payment Percentages and Examples
An official Quigley Trust notice dated November 10, 2025 states that, effective October 30, 2025, the payment percentage decreased to 13.3% for Non-Releasing Asbestos PI Claimants and 3.3% for Releasing Asbestos PI Claimants. The distinction depends on definitions in the Trust Distribution Procedures and a claimant’s settlement/release history.
| Mesothelioma Example | Scheduled Value | Mathematical Percentage Amount |
|---|---|---|
| Non-Releasing claimant at 13.3% | $200,000 | $26,600 |
| Releasing claimant at 3.3% | $200,000 | $6,600 |
These are mathematical illustrations only. Actual payment depends on claim qualification, claimant category, liquidated value, the payment percentage applicable under the TDP at payment and any other governing trust provisions. Compensation is not guaranteed.
Need help reviewing Quigley exposure records? Call 800.291.0963. Live chat available 24/7, 365 days a year. Submit Your Case.
Exposure and Medical Requirements
The Quigley Trust Distribution Procedures require disease-specific medical and exposure evidence. For Level VII mesothelioma, the TDP lists a diagnosis of mesothelioma and Quigley Exposure. Other disease levels can require additional occupational-exposure evidence.
Official filing instructions state that the claim form requires the occupation and industry in which Quigley Exposure occurred. Depending on the disease level and review method, supporting evidence may include medical records, employment history, worksite information, product identification and evidence of significant occupational exposure.
Quigley’s historical asbestos-containing products included Insulag and Panelag. Product or worksite evidence must still connect the individual claimant to qualifying Quigley Exposure under the trust’s procedures.
Confirmed Primary Sources for Trust Facts
Statistics and claim information on this page are checked against official or primary records rather than law-firm or lead-generation websites.
- Quigley Company, Inc. Asbestos PI Trust official website: trust creation, claims-filing dates and current claim resources.
- Quigley Trust Conformed Trust Distribution Procedures: disease criteria, scheduled values, average values, maximum values, review methods and payment-percentage rules.
- Quigley Asbestos PI Trust November 10, 2025 notice: current 13.3% Non-Releasing and 3.3% Releasing payment percentages effective October 30, 2025.
- Quigley official claim-filing instructions: exposure evidence, filing procedures, releases and payment mechanics.
- Pfizer SEC filings: reorganization effectiveness and approximately $1.08 billion historical contribution value.
- U.S. Bankruptcy Court for the Southern District of New York: bankruptcy history, historical asbestos-claim estimate and earlier reorganization funding proposals.
Not published without acceptable confirmation: a current trust asset balance, cumulative claims paid, annual claims paid or lifetime dollars paid. Those figures can be added when an official annual report, audited financial statement, bankruptcy filing or equivalent primary record confirms them.
Other Trust and Legal Options
Quigley exposure may have occurred alongside asbestos products made by other companies. Depending on the evidence, a claimant may need to investigate additional asbestos trusts or other legal options. Qualification for the Quigley Trust does not automatically establish qualification for another trust or lawsuit.
Related Asbestos Trust Fund Resources
Manufacturer Trust Information
Filing and Eligibility
- Step-by-Step Guide to Filing an Asbestos Trust Claim
- Asbestos Trust Fund Requirements
- How to Avoid Trust Fund Filing Errors
Payments and Legal Strategy
Quigley Asbestos Trust FAQs
When was the Quigley Asbestos PI Trust created?
The official trust website states that the Quigley Company, Inc. Asbestos Personal Injury Trust was created in 2013 following confirmation of Quigley’s Chapter 11 reorganization plan.
How much was contributed when the Quigley reorganization became effective?
Pfizer’s SEC filing reports approximately $1.08 billion in cash and non-cash items contributed to Reorganized Quigley and the Asbestos PI Trust when the amended plan became effective in November 2013. This is a historical contribution value, not a current trust balance.
How many asbestos claims did Quigley estimate at bankruptcy?
The bankruptcy court reported Quigley’s estimate of approximately 212,000 pending or expected asbestos personal-injury claims as of the petition date. This is not a count of claims ultimately paid by the trust.
What is the Quigley mesothelioma scheduled value?
The current conformed TDP lists a $200,000 scheduled value for Level VII mesothelioma and a $450,000 maximum Individual Review value. Neither amount is a guaranteed payment.
What is the current Quigley Trust payment percentage?
Effective October 30, 2025, the official trust notice sets the percentage at 13.3% for Non-Releasing claimants and 3.3% for Releasing claimants, subject to the TDP and future changes.
Why are there two Quigley payment percentages?
The TDP distinguishes Releasing and Non-Releasing Asbestos PI Claimants based on specified settlement and release circumstances. The claimant category affects the applicable percentage.
What evidence is needed for a Quigley asbestos claim?
The trust requires disease-specific medical evidence and Quigley Exposure evidence. Depending on the disease level, additional significant occupational-exposure evidence may be required.
How many claims has the Quigley Trust paid?
This page does not publish a cumulative paid-claim number unless it can be confirmed from an acceptable official annual report, audited financial statement, bankruptcy filing or equivalent primary record.
Get Help Reviewing a Quigley Asbestos Trust Claim
If you or a family member has been diagnosed with mesothelioma, asbestos-related lung cancer or another asbestos-related disease and you are investigating Quigley exposure, a claim review can help organize potentially relevant medical, employment, product and worksite evidence.
Call 800.291.0963 to discuss the work history, products, worksites and years of possible exposure you remember. Live chat is available 24/7, 365 days a year. Submit Your Case using the form below.
Prior asbestos exposure does not automatically establish eligibility for a trust claim or lawsuit. Trust availability, eligibility, filing requirements, payment percentages and legal options depend on current procedures, evidence and individual circumstances. Compensation is not guaranteed.
⚕️ Legal & Medical Information Disclaimer
This page provides general educational information and is not medical or legal advice. The information does not establish asbestos exposure, diagnosis, causation, liability, claim eligibility or compensation. Medical concerns should be discussed with a qualified healthcare professional, and legal questions should be reviewed with a qualified attorney.